Copyright
©The Author(s) 2023.
World J Diabetes. Mar 15, 2023; 14(3): 209-221
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.209
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.209
Figure 3 miR-124 targeted EZH2 and downregulated the expression of EZH2.
A: miR-124 targeted EZH2 verified by a double luciferase reporter gene assay. B: The relative expression levels of EZH2 mRNA were upregulated by miR-124 inhibitor in high glucose-induced Min6 cells detected by real-time quantitative polymerase chain reaction; C: The relative expression of EZH2 protein was upregulated by miR-124 inhibitor in HG-induced Min6 cells detected by western blot. aP < 0.05, vs the mimic-NC group; bP < 0.05, vs BC group; cP < 0.05, vs the HG group. NC: Normal control; BC: Blank control; HG: High glucose.
- Citation: Duan XK, Sun YX, Wang HY, Xu YY, Fan SZ, Tian JY, Yu Y, Zhao YY, Jiang YL. miR-124 is upregulated in diabetic mice and inhibits proliferation and promotes apoptosis of high-glucose-induced β-cells by targeting EZH2. World J Diabetes 2023; 14(3): 209-221
- URL: https://www.wjgnet.com/1948-9358/full/v14/i3/209.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i3.209